POMC
Pro-opiomelanocortin
Also known as: ACTH, CLIP, COLI_HUMAN, LPH, MSH, NPP, POC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01189
- Gene
- POMC
- Ensembl
- ENSG00000115138
- Chromosome
- 2
- Canonical length
- 267 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a preproprotein that undergoes extensive, tissue-specific, post-translational processing via cleavage by subtilisin-like enzymes known as prohormone convertases. There are eight potential cleavage sites within the preproprotein and, depending on tissue type and the available convertases, processing may yield as many as ten biologically active peptides involved in diverse cellular functions. The encoded protein is synthesized mainly in corticotroph cells of the anterior pituitary where four cleavage sites are used; adrenocorticotrophin, essential for normal steroidogenesis and the maintenance of normal adrenal weight, and lipotropin beta are the major end products. In other tissues, including the hypothalamus, placenta, and epithelium, all cleavage sites may be used, giving rise to peptides with roles in pain and energy homeostasis, melanocyte stimulation, and immune modulation. These include several distinct melanotropins, lipotropins, and endorphins that are contained within the adrenocorticotrophin and beta-lipotropin peptides. The antimicrobial melanotropin alpha peptide exhibits antibacterial and antifungal activity. Mutations in this gene have been associated with early onset obesity, adrenal insufficiency, and red hair pigmentation. Alternatively spliced transcript variants encoding the same protein have been described. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
267 residues, UniProt reviewed canonical sequence.
>P01189|POMC
1 MPRSCCSRSG ALLLALLLQA SMEVRGWCLE SSQCQDLTTE SNLLECIRAC KPDLSAETPM
61 FPGNGDEQPL TENPRKYVMG HFRWDRFGRR NSSSSGSSGA GQKREDVSAG EDCGPLPEGG
121 PEPRSDGAKP GPREGKRSYS MEHFRWGKPV GKKRRPVKVY PNGAEDESAE AFPLEFKREL
181 TGQRLREGDG PDGPADDGAG AQADLEHSLL VAAEKKDEGP YRMEHFRWGS PPKDKRYGGF
241 MTSEKSQTPL VTLFKNAIIK NAYKKGELocalizationUniProt · AlphaFold · HPA
Whether an antibody against POMC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 30,727 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 30,727 nTPM
- hypothalamus: 48 nTPM
- skin: 30 nTPM
- testis: 25 nTPM
- pancreas: 21 nTPM
- adrenal gland: 17 nTPM
Single-cell type
- corticotrophs: 97,131 nCPM
- late spermatids: 642 nCPM
- pituitary stem cells: 372 nCPM
- somatotrophs: 365 nCPM
- epididymal efferent duct absorptive cells: 364 nCPM
- epididymal principal cells: 171 nCPM
Immune cell
- plasmacytoid DC: 28 nTPM
- NK-cell: 18 nTPM
- naive B-cell: 18 nTPM
- memory B-cell: 17 nTPM
- myeloid DC: 16 nTPM
- intermediate monocyte: 13 nTPM
Brain region
- hypothalamus: 68 nTPM
- medulla oblongata: 7.6 nTPM
- spinal cord: 6 nTPM
- pons: 5.7 nTPM
- thalamus: 5.1 nTPM
- white matter: 4.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about POMC.
Disease | AllUniProt
Conditions POMC is implicated in, by any mechanism.
- Obesity (OBESITY) MIM:601665
- Obesity, early-onset, with adrenal insufficiency and red hair (OBAIRH) MIM:609734
Disease | GeneticClinVar
21 pathogenic / likely-pathogenic of 212 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Obesity due to pro-opiomelanocortin deficiency
- Early onset severe obesity
- POMC-related disorder
- Obesity
- Inborn genetic diseases
Disease | AutoantibodyPubMed
Conditions in which antibodies against POMC are reported. Each links to that disease's full target list.
Showing 0 of 1 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for POMC from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
11 publications
- Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome.
2021 · Cancer Immunol Immunother · RCR 3.4 · 51 citations - Autoantibodies against alpha -MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients.
2002 · Proc Natl Acad Sci U S A · RCR 2.5 · 106 citations - Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns.
2014 · Proc Natl Acad Sci U S A · RCR 2.2 · 63 citations - Long-Term Dynamics of Serum α-MSH and α-MSH-Binding Immunoglobulins with a Link to Gut Microbiota Composition in Patients with Anorexia Nervosa.
2024 · Neuroendocrinology · RCR 2.2 · 8 citations - Altered Serum Immunological and Biochemical Parameters and Microbiota Composition in Patients With AN During Realimentation.
2021 · Front Nutr · RCR 1.5 · 19 citations
Show 6 more
- Paraneoplastic isolated adrenocorticotropic hormone deficiency revealed after immune checkpoint inhibitors therapy: new insights into anti-corticotroph antibody.
2023 · Front Immunol · RCR 1.5 · 10 citations - Isolated adrenocorticotropic hormone deficiency as a form of paraneoplastic syndrome.
2018 · Pituitary · RCR 1.4 · 28 citations - Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease.
2011 · J Neuroimmunol · RCR 0.7 · 23 citations - Effects of rabbit anti-α-melanocyte-stimulating hormone (α-MSH) immunoglobulins on α-MSH signaling related to food intake control.
2014 · Neuropeptides · RCR 0.6 · 18 citations - Plasma enterobacterial ClpB levels and ClpB- and α-MSH-reactive immunoglobulins in lung cancer patients with and without anorexia.
2020 · Nutrition · RCR 0.5 · 10 citations - Intestinal inflammation influences α-MSH reactive autoantibodies: relevance to food intake and body weight.
2012 · Psychoneuroendocrinology · RCR 0.5 · 19 citations
Reference: B cellIEDB
1 publication
- Autoantibodies reactive to adrenocorticotropic hormone can alter cortisol secretion in both aggressive and nonaggressive humans.
2018 · Proc Natl Acad Sci U S A · RCR 0.5 · 11 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.38
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.1
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium-mediated signaling
- cell-cell signaling
- generation of precursor metabolites and energy
- glucose homeostasis
- negative regulation of tumor necrosis factor production
- neuropeptide signaling pathway
- positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway
- positive regulation of transcription by RNA polymerase II
- regulation of appetite
- regulation of blood pressure
- regulation of corticosterone secretion
- regulation of glycogen metabolic process
- response to melanocyte-stimulating hormone
- signal transduction
- cellular pigmentation
- positive regulation of oxytocin production
Molecular functions
- G protein-coupled receptor binding
- hormone activity
- signaling receptor binding
- type 1 melanocortin receptor binding
- type 3 melanocortin receptor binding
- type 4 melanocortin receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Pro-opiomelanocortin
- Pro-opiomelanocortin/corticotropin, ACTH, central region
- Opiodes neuropeptide
- Pro-opiomelanocortin N-terminal
- Pro-opiomelanocortin-derived peptides
- Corticotropin ACTH domain
- Opioids neuropeptide
- Pro-opiomelanocortin, N-terminal region
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POMC as an antibody target. Whether an autoantibody or antibody against POMC could matter depends on whether native POMC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POMC is annotated as secreted, so native POMC circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label POMC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...